Clinical Trials Logo

Weight Gain clinical trials

View clinical trials related to Weight Gain.

Filter by:

NCT ID: NCT03877562 Completed - Clinical trials for Antipsychotic-induced Weight Gain

The Effect of CORT118335 on Olanzapine-Induced Weight Gain

Start date: April 1, 2019
Phase: Phase 1
Study type: Interventional

This study will investigate if there is any difference in the amount of weight gained by participants taking olanzapine with CORT118335 compared with olanzapine with placebo (a dummy test medicine which looks like CORT118335 but contains no active medicine). Safety and tolerability of CORT118335 when taken with olanzapine will also be evaluated.

NCT ID: NCT03841591 Completed - Clinical trials for Gestational Diabetes

Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin

Start date: February 1, 2018
Phase: Phase 3
Study type: Interventional

Insulin has many disadvantages for mothers with GDM including the need to give injections, frequent daily testing for monitoring, and risks of hypoglycemia, increase in appetite, weight gain and high cost. Metformin, an oral biguanide, may be a more logical alternative to insulin for women with GDM who are unable to cope with the increasing insulin resistance of pregnancy. This study aim to compare maternal weight gain during pregnancy in women with gestational diabetes, treated by insulin versus metformin.

NCT ID: NCT03834194 Completed - Clinical trials for Gestational Weight Gain

Gestational Weight and Incentive Research Study

Bloom
Start date: February 26, 2019
Phase: N/A
Study type: Interventional

Bloom is a research study that examines whether incentives for daily self-weighing, weekly physical activity, monthly weight management or overall (from enrollment up to 36 weeks pregnancy) weight management could help pregnant mothers manage a health weight gain during pregnancy.

NCT ID: NCT03818256 Completed - Clinical trials for Antipsychotic-induced Weight Gain (AIWG)

This Phase 2, Double Blind, Placebo-controlled, Randomized Study is to Assess the Safety and Efficacy of Miricorilant in Obese Adult With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications.

Start date: October 31, 2019
Phase: Phase 2
Study type: Interventional

This phase 2, double blind, placebo-controlled, randomized study is to assess the safety and efficacy of miricorilant in obese adult with schizophrenia treated with antipsychotic medications.

NCT ID: NCT03785821 Completed - Weight Gain Clinical Trials

Effect of Bitter Melon Seed Oil on Body Weight

Start date: April 1, 2016
Phase: N/A
Study type: Interventional

To investigate the metabolic benefits of bitter melon seed oil (BMSO), overweight or obese healthy Taiwanese adults (n=60) were randomly assigned to receive capsules containing either olive oil (OO; placebo) or BMSO at 4.5 g/d dose for 12 week. Across intervention period, body weight, BMI, waist-to-hip ratio, and body fat mass were measured. Blood were collected before and after intervention for measurements of blood lipid and inflammatory cytokines. The anti-obesity effect of BMSO was further assessed by stratification of participants according to UCP1 rs1800592 polymorphism.

NCT ID: NCT03767699 Completed - Clinical trials for Gestational Weight Gain

Medical Nutrition Therapy Program and Eating Behavior Questionnaires on Gestational Weight Gain

Start date: November 2013
Phase:
Study type: Observational

Type 2 Diabetes Mellitus (T2DM) and Gestational Diabetes Mellitus (GDM) create complications during pregnancy, particularly in women with gestational weight gain (GWG) that falls over the recommended limit. On the other hand Medical nutrition therapy (MNT) has been shown to reduce some complications in women with T2DM and GDM. The aim of this project was to assess the association of MNT consultations and eating behavior with GWG in Mexican women with T2DM and GDM.

NCT ID: NCT03759847 Completed - Weight Gain Clinical Trials

Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis

Start date: January 23, 2019
Phase: N/A
Study type: Interventional

Methods are needed to help decrease interdialytic weight gains in hemodialysis patients. One potential method for accomplishing this goal is to develop an app for smartphones that allow patients to track their fluid intake throughout the course of the day. This protocol is designed to test the safety and efficacy of this app, followed by use of the app in patients with large fluid weight gains between HD sessions. In the Vanguard phase, patients without large interdialytic fluid gains (less than 4%) will use the app to to determine the association between the interdialytic weight gain and the fluid consumed as recorded by use of the app for each interdialytic period. The app will be modified, if needed, prior to initiation of the full scale trial.

NCT ID: NCT03718000 Completed - Obesity Clinical Trials

Daily Self-weighing and Holiday-associated Weight Gain in Adults

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Background: Previous studies report 0.4-1.5kg of weight gain during the holiday season, which may contribute to annual weight gain. Purpose: To test whether daily self-weighing (DSW) can prevent holiday weight gain. Hypothesis: We hypothesized that daily self-weighing would effectively prevent weight and fat gain, and that individuals with overweight and obesity would respond most favorably to DSW.

NCT ID: NCT03717428 Completed - Weight Gain Clinical Trials

Preventing Age-Related Weight Gain in the Workplace With Daily Weighing

Weigh2Go
Start date: October 1, 2016
Phase: N/A
Study type: Interventional

To examine the effectiveness of daily weighing to prevent age-related weight gain.

NCT ID: NCT03699059 Completed - Obesity Clinical Trials

The wEight Management in Renal Transplant Online Study (ExeRTiOn)

ExeRTiOn
Start date: May 31, 2018
Phase: N/A
Study type: Interventional

The primary aim of this project is to create an online weight management tool (Physical activity, weight management and cognitive behavioral therapy) to prevent significant weight gain following kidney transplantation. Designing the online interactive weight management resource for kidney transplant patients will involve patient and health care professional input through Qualitative methodology such as 'Think-Aloud' interviews and one-to-one semi-structured interviews. This online resource will be called "exertion" and will be created by the research team, with technical support from the Software Company (SPIKA). Results from this study will refine the resource, and lead to a study application for a randomized controlled feasibility trial where we plan to test the "exertion" online application. Therefore this project has potential to influence clinical practice for kidney transplant recipients. It will allow patients, who may not have routine access to physio or dietetic input to address weight gain with support. A study flow chart summarizing the project can be found below.